Paysign Inc. Reports Significant Increase in Sales and Net Income for Fiscal Period, EPS Exceeds Expectations

Reuters
2025/06/04
<a href="https://laohu8.com/S/PAYS">Paysign Inc</a>. Reports Significant Increase in Sales and Net Income for Fiscal Period, EPS Exceeds Expectations

Paysign Inc., a leading provider of prepaid card programs and payment processing solutions, has released its financial results. The company reported a variation in Adjusted EBITDA, a non-GAAP measure, which excludes stock-based compensation charges. Paysign emphasizes that EBITDA and Adjusted EBITDA are not indicators of cash flows from operations or net income as defined by U.S. GAAP. The financial results also highlight the company's commitment to technology advancements aimed at reducing administrative costs, streamlining operations, and driving revenue for its customers. No specific figures regarding sales/revenues, net income/profit/loss, or earnings per share $(EPS)$ were disclosed in the document. The company also provides customized, scalable solutions with a strong focus on the healthcare industry. Paysign is headquartered in southern Nevada and has been in operation for over 20 years, partnering with major pharmaceutical and healthcare companies as well as multinational corporations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Paysign Inc. published the original content used to generate this news brief on June 04, 2025, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10